Nordic Life Sience NO 04
Published: November 13, 2020
Top stories
Acquisition – July 20, 2026
The offer values PolyPeptide’s equity at approximately CHF 1.46 billion.
Careers article – July 19, 2026
Thomas Karikari’s career has taken him across three continents: from Ghana to the UK and Sweden, and then to the US. Now an Associate Professor at the University of Pittsburgh and one of Nature Index’s “rising stars in ageing research”, he is helping move Alzheimer’s blood biomarkers beyond individual markers and towards a more complete picture of disease biology.
The magazine – July 17, 2026
We would like to thank our readers, subscribers and collaboration partners for a fruitful and eventful Q1 + Q2 2026, and we wish you all a most wonderful summer!
New Market – July 16, 2026
The European Commission (EC) has granted marketing authorisation for Wegovy pill (once-daily oral semaglutide 25 mg) for the treatment of adults with obesity (BMI ≥30 kg/m²) or overweight (BMI ≥27 kg/m²) with at least one weight-related comorbidity, as an adjunct to a reduced-calorie diet and increased physical activity.
Related posts
This site uses cookies